clarithromycin has been researched along with Gastric Diseases in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (20.00) | 18.2507 |
| 2000's | 15 (50.00) | 29.6817 |
| 2010's | 8 (26.67) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, YS; Kim, HY; Kim, S; Noh, SJ; Park, CH; Park, JH; Sohn, CI | 1 |
| Fuchigami, T; Kawasaki, K; Kurahara, K; Matsumoto, T; Nakamura, S; Ohtsu, K; Oshiro, Y | 1 |
| Hwang, JJ; Kim, N; Lee, AR; Lee, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Chen, A; Hsu, PI; Hsu, WH; Kuo, CH; Tsay, FW; Wu, DC | 1 |
| Bojic, B; Cakic, S; Dapcevic, B; Jankovic, Lj; Milasin, J; Popovic, B; Zaric, S | 1 |
| Strobl, S; Zuber-Jerger, I | 1 |
| Assumpção, MB; Barile, KA; Corvelo, TC; Silva, AL; Xavier, JN | 1 |
| Aurer, A; Bago, I; Bago, J; Budimir, A; Majstorović, K; Plečko, V | 1 |
| Bauerfeind, P; Kaiser, P; Misselwitz, B; Vavricka, SR | 1 |
| Carmine, P; Cinquepalmi, V; Giorgio, F; Ierardi, E; Monno, R; Soleo, L | 1 |
| Coyle, W; Dunteman, T; Nemec, R; Sullivan, B | 1 |
| Chiba, N; Fischbach, L; Khurana, R; Veldhuyzen van Zanten, S | 1 |
| Demirturk, L; Gurbuz, AK; Ozel, AM; Ozturk, R; Yazgan, Y; Yildirim, S | 1 |
| Aoki, T; Itoi, T; Kawai, T; Kawakami, K; Matsumoto, Y; Mikinori, K; Moriyasu, F; Noguchi, N; Rimbara, E; Sasatsu, M; Takagi, Y; Takei, K; Watanebe, K | 1 |
| Cindoruk, M; Dursun, A; Erkan, G; Karakan, T; Unal, S | 1 |
| Beyer, J; Flamm, RK; Shortridge, D; Stamler, D; Stone, GG; Tanaka, SK | 1 |
| Harris, A | 1 |
| Cecchi, R; Torelli, E | 1 |
| Borody, TJ; Reyes, E; Shortis, NP | 1 |
| Neiger, R; Schmassmann, A; Seiler, G | 1 |
| Gutiérrez-Cabano, CA; Raynald, AC | 1 |
| Battaglia, G; Di Mario, F; Franceschi, M; Germanà, B; Leandro, G; Marin, R; Pilotto, A; Valerio, G | 1 |
| Cullen, DJ; McGechie, DB; Mollison, LC; Stingemore, N; Wake, RA | 1 |
| Ferraro, MJ; Fox, JG; Peña, JA; Versalovic, J | 1 |
| Chan, KL; Ng, DK; Tam, PK; Zhou, H | 1 |
| Kaisho, T; Kanamaru, T; Miyagawa, KI; Nakano, Y; Nakao, M; Tada, M; Toyoda, Y | 1 |
| Avcu, F; Avcu, N; Beyan, C; Kaptan , K; Nevruz, O; Ozyurt, M; Ural, AU; Yalçin, A | 1 |
| Antonenko, OM; Dicheva, DT; Lebedev, EG; Maev, IV; Ovsiannikova, EV; Shchekina, MI; V'iuchnova, ES | 1 |
5 review(s) available for clarithromycin and Gastric Diseases
| Article | Year |
|---|---|
[New options for helicobacter pylori antibiotic treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ofloxacin; Precision Medicine; Proton Pump Inhibitors; Retreatment; Stomach Diseases; Treatment Failure | 2011 |
An update on anti-Helicobacter pylori treatment in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Stomach Diseases | 2005 |
Current regimens for treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine; Stomach Diseases; Treatment Outcome | 1998 |
Eradication therapies for Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Organometallic Compounds; Stomach Diseases | 1998 |
[Experience in the use of losek (omeprazole) in gastroenterology].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Metronidazole; Omeprazole; Penicillins; Placebos; Randomized Controlled Trials as Topic; Stomach Diseases; Stomach Ulcer; Tablets; Time Factors; Zollinger-Ellison Syndrome | 2001 |
8 trial(s) available for clarithromycin and Gastric Diseases
| Article | Year |
|---|---|
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Multivariate Analysis; Odds Ratio; Pilot Projects; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Stomach Diseases; Time Factors; Treatment Outcome | 2015 |
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Dexlansoprazole; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Rabeprazole; Risk Factors; Stomach Diseases; Treatment Outcome | 2016 |
Periodontal therapy improves gastric Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Biofilms; Chlorhexidine; Clarithromycin; Dental Plaque; Dental Scaling; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Periodontal Attachment Loss; Periodontal Diseases; Periodontal Pocket; Prospective Studies; Proton Pump Inhibitors; Recurrence; Root Planing; Stomach Diseases; Young Adult | 2009 |
Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Prospective Studies; Stomach Diseases | 2002 |
Effect of N-acetyl cysteine on Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Expectorants; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Stomach Diseases | 2005 |
Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Phenotype; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Retreatment; Stomach Diseases; Treatment Outcome | 2007 |
Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nausea; Probiotics; Prospective Studies; Saccharomyces; Stomach Diseases; Treatment Outcome | 2007 |
Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Aging; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Diseases; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Stomach Diseases; Sulfoxides | 2000 |
17 other study(ies) available for clarithromycin and Gastric Diseases
| Article | Year |
|---|---|
Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Stomach Diseases; Treatment Outcome | 2023 |
Gastrointestinal: Idiopathic granulomatous gastritis observed by magnifying narrow-band imaging endoscopy.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Narrow Band Imaging; Rabeprazole; Stomach Diseases | 2017 |
[Differences between European guideline and planned S3 guideline of DGVS. Need for Helicobacter pylori eradication to be decided on an individual basis].
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Practice Guidelines as Topic; Proton Pump Inhibitors; Stomach Diseases | 2008 |
[Acute upper gastrointestinal bleeding after coronary intervention in acute myocardial infarction].
Topics: Aged; Amoxicillin; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Clarithromycin; Combined Modality Therapy; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Myocardial Infarction; Necrosis; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Stomach Diseases; Stomach Ulcer | 2010 |
Characterization of 23S rRNA domain V mutations in gastric biopsy patients from the eastern Amazon.
Topics: Anti-Bacterial Agents; Biopsy; Brazil; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach Diseases | 2010 |
The effectiveness of systemic eradication therapy against oral Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Chronic Periodontitis; Clarithromycin; Dental Plaque; DNA, Bacterial; Drug Combinations; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mouth Mucosa; Proton Pump Inhibitors; Saliva; Stomach Diseases | 2011 |
Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study.
Topics: Adult; Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach Diseases | 2012 |
[Reliable Helicobacter eradication. Combination package facilitates therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Packaging; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Pantoprazole; Patient Compliance; Stomach Diseases | 2006 |
PCR-RFLP typing of ureC from Helicobacter pylori isolated in Argentina from gastric biopsies before and after treatment with clarithromycin.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Biopsy; Clarithromycin; DNA Probes; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protein Synthesis Inhibitors; Reproducibility of Results; Serotyping; Stomach Diseases | 1997 |
Schönlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; IgA Vasculitis; Male; Middle Aged; Omeprazole; Penicillins; Stomach Diseases | 1998 |
Use of a urea breath test to evaluate short-term treatments for cats naturally infected with Helicobacter heilmannii.
Topics: Animals; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Azithromycin; Biopsy; Bismuth; Breath Tests; Carbon Dioxide; Carbon Radioisotopes; Cat Diseases; Cats; Clarithromycin; Female; Gas Chromatography-Mass Spectrometry; Helicobacter; Helicobacter Infections; Male; Metronidazole; Polymerase Chain Reaction; Prospective Studies; Random Allocation; Ranitidine; Stomach Diseases; Tinidazole; Urea | 1999 |
Gastroprotective effect of intragastric clarithromycin against damage induced by ethanol in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Anti-Bacterial Agents; Body Water; Clarithromycin; Cyclooxygenase Inhibitors; Ethanol; Female; Gastric Mucosa; Gastrointestinal Contents; Gastrointestinal Motility; Indomethacin; Iodoacetamide; Male; Rats; Rats, Wistar; Regional Blood Flow; Stomach; Stomach Diseases; Sulfhydryl Reagents; Yohimbine | 1999 |
Antibiotic resistance in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Stomach Diseases; Western Australia | 2000 |
Molecular resistance testing of Helicobacter pylori in gastric biopsies.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA Primers; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Microbial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Stomach Diseases; Urease | 2001 |
A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Prospective Studies; Stomach Diseases | 2001 |
In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Microbial; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Indoles; Male; Microbial Sensitivity Tests; Penicillins; Stomach Diseases; Tryptophan-tRNA Ligase | 2001 |
The relationship between gastric-oral Helicobacter pylori and oral hygiene in patients with vitamin B12-deficiency anemia.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anemia, Pernicious; Anti-Bacterial Agents; Anti-Ulcer Agents; Campylobacter; Chi-Square Distribution; Clarithromycin; Dental Calculus; Dental Plaque; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Oral Hygiene; Oral Hygiene Index; Penicillins; Recurrence; Statistics as Topic; Stomach Diseases; Vitamin B 12; Vitamin B 12 Deficiency | 2001 |